Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000818033-10-000024
Filing Date
2010-02-19
Accepted
2010-02-19 14:36:31
Documents
2
Period of Report
2010-02-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3064
2 EDGAR SUPPORTING DOCUMENT appadavis021910.txt EX-24 3311
  Complete submission text file 0000818033-10-000024.txt   8260
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
AP PHARMA INC /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NEUROGEN CORP 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address
DAVIS STEPHEN (Reporting) CIK: 0001131146 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33221 | Film No.: 10619263